Women’s Health Devices Market (By Application: Chronic Diseases, General Health, Reproductive Health, Pelvic & Uterine Health, Others; By End Users: Hospitals & Clinics, Home Healthcare, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global women’s health devices market size was valued at US$ 31 billion in 2022 and is expected to reach over US$ 70.41 billion by 2032 with a registered CAGR of 8.60% from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. women’s health devices market size was estimated at US$ 6.14 billion in 2022 and is projected to grow around US$ 14.07 billion by 2032 with a CAGR of 8.1% between 2023 to 2032.
North America was the dominant women’s health devices market in 2022. The high healthcare expenditure on women’s health and higher adoption of the advanced healthcare devices among the women population in North America has driven the market growth in this region. Moreover, the presence of huge female population in the region along with the favorable reimbursement policies of the government has fostered the market growth in this region in the past few years. Moreover, around 60% of the US population is suffering from one or more chronic diseases and this is a major factors that has contributed towards the growth of the women’s health devices market. The growing investments in the research & development, clinical trials, and marketing of new health devices by the top market players in the region is expected to further boost the demand for the women’s health devices across US and Canada.
The Asia Pacific is estimated to be the most opportunistic market during the forecast period. The increased government initiatives to promote gender equality in the nation like India and China have resulted in a surge in the women population. Moreover, the rising participation of women in the workforce is resulting in the increased disposable income of the women. Apart from this, the improving access to healthcare infrastructure is boosting the growth of the women’s health devices market in Asia Pacific. The rising prevalence of various chronic diseases such as cancer, diabetes, cardiovascular diseases, and respiratory disorders among the women population is expected to augment the growth of the Asia Pacific women’s health devices market.
A strong growth in the women’s healthcare expenditure has been witnessed across the globe. The growing focus on the women’s healthcare coupled with the increased personal disposable income of the women has fostered the growth of the women’s health devices market across the globe. The rising participation of the women in the workforce especially in the developed nations has significantly contributed towards the growth of the market. Moreover, the rising prevalence of chronic diseases like cancer, cardiovascular diseases, and diabetes among the women population is fueling the growth of the global women’s health devices market. According to the International Agency for Research on Cancer, the female breast cancer has become the most diagnosed type of cancer by surpassing the lungs cancer. Around 2.3 million new cases of breast cancer were reported in 2020. Around 9.2 million new cases of cancer and 4.4 million cancer deaths in female were reported in 2020. These numbers are boosting the healthcare expenditure in the women’s health devices.
The lack of awareness regarding the female genital health and sanitization along with the underdeveloped healthcare infrastructure in the developing and the underdeveloped markets is presenting a huge growth opportunity to the market players. Furthermore, the rapidly growing geriatric population is expected to drive the market growth in the foreseeable future. According to the World Health Organization, the global geriatric population is expected to reach at 2 billion by 2050. Moreover, improving gender ratio in the developing nations owing to the government initiatives is expected to foster the growth of the women’s health devices market in the forthcoming years. Further, the rising complications related to the women’s fertility owing to the delayed marriage and pregnancy is fostering the demand for the women’s health devices across the globe. Rising government initiatives regarding the women empowerment and women health especially in the developing countries like India is resulting in growth of the women’s health devices market. The rising expenditure of the medical devices manufacturing companies for the development of the women focused health and medical devices is significantly fostering the growth of the market across the globe.
| Report Coverage | Details |
| Market Size | US$ 70.41 Billion by 2032 |
| Growth Rate | CAGR of 8.60% from 2023 to 2032 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Type, Product, Application, Region |
| Companies Mentioned | GE Healthcare, F. Hoffmann-La Roche, Hologic, Koninklijke Philips, Siemens AG, Prestige Consumer Healthcare, Inc., Abbott Laboratories, Caldera Medical, MedGyn Products, Medline Industries, Carestream Health |
Based on the application, the global women’s health devices market was dominated by chronic diseases segment. The various chronic diseases such as cancer, diabetes, cardiovascular diseases, and various others is rising at an alarming rate among the women owing to changing lifestyle, physical inactivity, and changing food habits. Cancer is the most dominant chronic disease among the female population. The rising burden of breast cancer, colorectum cancer, ovarian cancer, and lungs cancer among the women population has significantly contributed towards the growth of this segment across the globe.
The pelvic & uterine health is estimated to be the most opportunistic segment during the forecast period. According to the UCLA Health, one in three women are affected with the pelvic floor disorders once in their lifetime. The rising prevalence of the pelvic floor disorder, rising awareness regarding the vaginal disorders, and increasing prevalence of the urinary and fecal incontinence among the women population are the major factors that are expected to drive the growth of this segment during the forecast period.
The hospitals & clinics segment dominated the global women’s health devices market in 2022. This is simply attributable to the increased preference for the hospital services among the population for receiving treatment for majority of the diseases. The increased penetration of public and private hospitals, rising number of private clinics, strong and developed infrastructure for treatment and diagnosis at hospitals, and availability of special wards for serving women at hospitals are the major factors that has fostered the growth of the hospitals & clinics segment.
The home healthcare is estimated to be the fastest-growing segment during the forecast period. The rising disposable income, rising healthcare expenditure, growing awareness regarding the hospital acquired infections, and easy availability of the home healthcare services are the prominent factors that are expected to augment the demand for the home healthcare segment in the forthcoming years.
Key Market Developments
The various developmental strategies like acquisitions and mergers fosters market growth and offers lucrative growth opportunities to the market players.
Segments Covered in the Report
By Type
By Product
By Application
By End User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Women’s Health Devices Market
5.1. COVID-19 Landscape: Women’s Health Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Women’s Health Devices Market, By Product
8.1. Women’s Health Devices Market, by Product Type, 2023-2032
8.1.1. Surgical
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Diagnostics
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Contraceptives
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Labor & Delivery
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Critical Care
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Women’s Health Devices Market, By Type
9.1. Women’s Health Devices Market, by Type, 2023-2032
9.1.1. Devices
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Consumables
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Women’s Health Devices Market, By Application Type
10.1. Women’s Health Devices Market, by Application Type, 2023-2032
10.1.1. Chronic Diseases
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. General Health
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Reproductive Health
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Pelvic & Uterine Health
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Cancer
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Infectious Disease
10.1.6.1. Market Revenue and Forecast (2020-2032)
10.1.7. Uterine Fibroids
10.1.7.1. Market Revenue and Forecast (2020-2032)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Women’s Health Devices Market, By End User Type
11.1. Women’s Health Devices Market, by End User Type, 2023-2032
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Home Healthcare
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Obstetrics & Gynecology Clinics
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Diagnostic Laboratories
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Ambulatory Surgical Centers
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Women’s Health Devices Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Forecast, by Type (2020-2032)
12.1.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.1.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Type (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Type (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Forecast, by Type (2020-2032)
12.2.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Type (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Type (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Type (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Type (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Forecast, by Type (2020-2032)
12.3.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Type (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Type (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Type (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Type (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Forecast, by Type (2020-2032)
12.4.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Type (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Type (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Type (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Type (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Forecast, by Type (2020-2032)
12.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.5.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Type (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End User Type (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Type (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application Type (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End User Type (2020-2032)
Chapter 13. Company Profiles
13.1. GE Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann-La Roche
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Hologic
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Koninklijke Philips
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Prestige Consumer Healthcare, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Abbott Laboratories
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Caldera Medical
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. MedGyn Products
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medline Industries
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Carestream Health
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
